A. This was the number of dead who were not transferred by us to another department, but who died at our station or a few hours after they had been transferred to another station.
Q. Have you any knowledge as to what happened to some of the other patients who were transferred to some other station after they were experimented on? That is, did some others die after they were experimented on?
A. Of our patients, during the years after they came to us for observation, I can recollect that another 60 patients died. I cannot say for certain they died of malaria or other results of the experiments.
CROSS-EXAMINATION
Dr. Fritz: I have a few questions to ask the witness. Witness, on Friday you seemed to be fairly well acquainted with certain malaria questions, obviously on the basis of knowledge gained with Professor Schilling. I would now like to ask you the following questions concerning some very important details: During your examination by the prosecuting counsel you spoke of certain regrettable incidents. A number of deaths had occurred during the course of the malaria experiments conducted by Professor Schilling. At the time you mentioned about seven cases, but you only described one in detail. The patient had yellow fever in addition to malaria and then bled to death because the liver was punctured. I now ask you to tell me something about the reasons for the other six deaths.
Witness Vieweg: The other six patients were the so-called “medicament death” cases. One patient died as a result of the salvarsan drug. The other one died as a result of the so-called “periphery” experiment, and the last four died as the result of a pyramidon experiment.
Q. Were the patients who, after being released from the station of Schilling, suffered relapses sent back to Professor Schilling’s station?
A. If they reported back to us, they were taken back to the station.
Q. In that case did any patients die in Professor Schilling’s department who later on had malaria or relapses?